Investor Relations Home

2014 Annual Report
2014 Annual Report
2012 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
  
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$88.53
Change (%) Stock is Up 1.37 (1.57%)
Volume764,517
Data as of 02/24/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports Fourth Quarter and Fiscal Year 2016 Financial Results
2016 Form 10K
2016 Proxy Statement
2014 Annual Report
Corporate Profile
We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, known as Masimo SET® pulse oximetry, but our product offerings have expanded significantly over the years to also include noninvasive blood constituent, brain and breath monitoring, including rainbow® Pulse CO-Oximetry, brain function electroencephalogram (EEG) monitoring, respiration rate, capnography and anesthetic agent monitoring. ... 
More >>
Upcoming EventsMore >>
There are currently no events scheduled.
Recent News
RSS Feeds RSS
| More >>
Masimo Announces Recent Study Monitoring Methemoglobin Levels During Administration of Inhaled Nitric Oxide - 02/21/17
IRVINE, Calif.--(BUSINESS WIRE)--Feb. 21, 2017-- Masimo (NASDAQ: MASI) announced today the findings of a recent study conducted on children admitted to a Ugandan hospital with fever and malaria, in which Masimo’s noninvasi... More >>
Masimo Announces CE Marking of Respiration Rate Measurement on MightySat™ Rx - 02/15/17
Masimo MightySat Rx is the First Fingertip Pulse Oximeter to Measure Respiration Rate NEUCHATEL, Switzerland--(BUSINESS WIRE)--Feb. 15, 2017-- Masimo (NASDAQ: MASI) announced today the CE marking of the measurement of ... More >>
Masimo Reports Fourth Quarter and Fiscal Year 2016 Financial Results - 02/14/17
Q4 2016 Highlights (compared to Q4 2015): Total revenue, including royalties, rose 9.5% to $183.2 million Product revenue rose 10.0% to $175.7 million Masimo rainbow® revenue ... More >>
Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring and Connectivity Platform - 02/01/17
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Feb. 1, 2017-- Masimo (NASDAQ: MASI) announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregate... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.